- Home
- NBP vs JRVR Comparison
NBP vs JRVR Comparison
Compare NBP & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBP | JRVR |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.5M | 209.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NBP | JRVR |
|---|---|---|
| Price | $1.97 | $4.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $9.00 | $7.33 |
| AVG Volume (30 Days) | 233.2K | ★ 235.2K |
| Earning Date | 04-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | N/A | ★ 125.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $687,614,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.46 | $3.76 |
| 52 Week High | $5.19 | $7.20 |
Technical Indicators
Market Signals| Indicator | NBP | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 64.83 | 39.08 |
| Support Level | $1.67 | $3.79 |
| Resistance Level | $2.27 | $4.36 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 96.15 | 31.41 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
About JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.